Loading interface...

Verteze-8 Tablet

Manufactured byTranscend Therapeutics Pvt. Ltd.
Description

Verteze-8 Tablet belongs to the class antivertigo which helps in the treatment of Meniere's disease which is an inner ear disorder. It is similar to that of a natural substance called histamine. This medicine is not recommended for use below 18 years of age.

Side effects

Major & minor side effects for Verteze-8 Tablet

  • Nausea and vomiting
  • Headache
  • Indigestion
  • Bloating
  • Skin rash and itching
  • Trouble sleeping
  • Fast heartbeat
  • Difficulty in breathing
  • Puffiness or swelling of the eyelids, around the eyes, face, lips, or tongue
  • Loss of consciousness
  • Abdominal pain

Uses of Verteze-8 Tablet

What is it prescribed for?

  • Meniere's disease
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 16 to 17 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    Habit-forming tendencies were reported
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use if you have a known history of allergy to betahistine or any other components present along with the formulation.

Pheochromocytoma

This medicine is not recommended for use in patients with a condition called pheochromocytoma (a tumor of the adrenal gland).
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Gastrointestinal disorder

This medicine may increase the risk of stomach ulcers. Inform the doctor if you have a history of peptic ulcer disease or any gastrointestinal disease. Drink an adequate amount of water to prevent stomach irritation. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Asthma

This medicine should be used with caution in patients with asthma due to the increased risk of worsening of the patient's condition. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Use in children

This medicine is not recommended for use in children below 18 years of age since safety and efficacy are not clinically established.

Missed Dose

Take the missed dose as soon as you remember it. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Monoamine oxidase inhibitors

antihistamines

Beta-2 agonists

Disease interactions

Pheochromocytoma

This medicine is not recommended for use in patients with a condition called pheochromocytoma (a tumor of the adrenal gland). Replacement with a suitable alternative should be done under your doctor's supervision.

Liver Disease

This medicine should be used with caution in patients suffering from liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney disease

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine exactly as prescribed by the doctor. Do not take in larger or smaller quantities than recommended. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Effect on sleep is not established

How it works
It works by increasing the blood flow in the inner ear thus reduces the pressure in the ear and prevents the symptoms.
Legal Status

Approved

Unknown

Approved

Approved

Classification

Category

Antivertigo agents

Schedule

Schedule H

Betahistine - DrugBank [Internet]. Drugbank.ca. 2017 [cited 25 October 2017]. Available from:

https://www.drugbank.ca/drugs/DB06698

[Internet]. Medicines.org.uk. 2020 [cited 2 March 2020]. Available from:

https://www.medicines.org.uk/emc/files/pil.7053.pdf

[Internet]. Mri.cts-mrp.eu. 2020 [cited 2 March 2020]. Available from:

http://mri.cts-mrp.eu/download/NL_H_1412_001_FinalPL.pdf

[Internet]. Medicine.abbott. 2020 [cited 2 March 2020]. Available from: ott/content/dam/bss/divisionalsites/epd/eg-en/documents/products-docs/Betaserc8-English.pdf

https://www.medicine.abb
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 10 Mar 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.